PTC Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
20.05.24
/
50%
€36.60
Target price
20.05.25
€42.34
Performance (%)
-12.57%
Price
02.10.24
€32.60
Summary
This prediction is currently active. The price of PTC Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.57%. This prediction currently runs until 20.05.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | -0.617% | -0.617% |
iShares Core DAX® | 1.308% | 1.167% |
iShares Nasdaq 100 | -0.156% | 1.246% |
iShares Nikkei 225® | 1.270% | 0.293% |
iShares S&P 500 | 0.476% | 1.292% |
Comments by Jefferies_Financial_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Jefferies Financial Group Inc. from $35.00 to $46.00. They now have a "buy" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€27.60
21.03.24
21.03.24
€32.14
21.03.25
21.03.25
15.94%
02.10.24
02.10.24